Mekiro Pharmaceutical Private Limited, a active private limited company, was established on 15 January 2020 in Thrissur, Kerala, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24234KL2020PTC061171. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.51 M.
Its leadership includes Sudheesh Venattu Sivan (Director), Elavanthra Janardhanan Jyothis (Director), Binuhassan Achanath Hassan (Director). It holds ₹4.49 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 53/506/7, First Floor, Triple F Arcade,, Panchikkal Road, Ayyanthole Ground,, Thrissur, Kerala, 680003.
U24234KL2020PTC061171
061171
15 January 2020
₹1.00 M
₹0.51 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Mekiro Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudheesh Venattu Sivan | Director | 15 Jan 2020 | Current |
| Elavanthra Janardhanan Jyothis | Director | 15 Jan 2020 | Current |
| Binuhassan Achanath Hassan | Director | 15 Jan 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mekiro Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 76.73% increase. The company also saw a substantial improvement in profitability, with a 77.27% increase in profit. The company's net worth Soared by an impressive increase of 100.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Mekiro Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹4,486,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2025 | State Bank Of India | ₹1.49 M | Open |
| 11 Oct 2022 | State Bank Of India | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mekiro Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mekiro Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mekiro Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with State Bank Of India amounted to Rs. 1.49 M with Charge ID 101122637 was registered on 19 Jun 2025. was documented.
Mekiro Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Mekiro Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
The activity A charge with State Bank Of India of Rs. 3.00 M registered on 11 Oct 2022 with Charge ID 100621415 was modified on 15 Jan 2024. was completed.
A charge with State Bank Of India amounted to Rs. 3.00 M with Charge ID 100621415 was registered on 11 Oct 2022. was recorded as a recent event.
Sudheesh Venattu Sivan was appointed as a Director was appointed as a Director on 15 Jan 2020 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
The CIN of Mekiro Pharmaceutical Private Limited is U24234KL2020PTC061171.
Mekiro Pharmaceutical Private Limited is headquartered at 53/506/7, First Floor, Triple F Arcade,, Panchikkal Road, Ayyanthole Ground,, Thrissur, Kerala, 680003.
Mekiro Pharmaceutical Private Limited was incorporated on 15 January 2020.
The current directors of Mekiro Pharmaceutical Private Limited are
The primary industry of Mekiro Pharmaceutical Private Limited is Hospital And Medical Care.
Mekiro Pharmaceutical Private Limited is unlisted.
The authorized capital of Mekiro Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.51 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX